< Back to Article

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study

Table 5

Results of Cox proportional hazards models for the effect of primaquine on the risk of re-presentation to hospital with P. vivax malaria within 3 months of being treated for P. vivax malaria.

Table 5